Xinxing Lai

1.2k total citations · 1 hit paper
27 papers, 643 citations indexed

About

Xinxing Lai is a scholar working on Epidemiology, Molecular Biology and Complementary and alternative medicine. According to data from OpenAlex, Xinxing Lai has authored 27 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 8 papers in Molecular Biology and 7 papers in Complementary and alternative medicine. Recurrent topics in Xinxing Lai's work include Acute Ischemic Stroke Management (8 papers), Neurological Disease Mechanisms and Treatments (5 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Xinxing Lai is often cited by papers focused on Acute Ischemic Stroke Management (8 papers), Neurological Disease Mechanisms and Treatments (5 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Xinxing Lai collaborates with scholars based in China. Xinxing Lai's co-authors include Shao Li, Peng Zhang, Mingran Yang, Shiyu Du, Aidi Tan, Yiding Zhang, Shuai Xiao, Wuai Zhou, Jianyang Zeng and Kuo Yang and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Journal of Ethnopharmacology.

In The Last Decade

Xinxing Lai

23 papers receiving 628 citations

Hit Papers

Dissecting the Single-Cell Transcriptome Network Underlyi... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinxing Lai China 10 301 134 122 117 107 27 643
Ziqi Meng China 16 378 1.3× 149 1.1× 49 0.4× 99 0.8× 48 0.4× 31 635
Xuguang Hu China 15 379 1.3× 163 1.2× 66 0.5× 107 0.9× 90 0.8× 48 814
Jian Hao China 14 244 0.8× 74 0.6× 60 0.5× 125 1.1× 47 0.4× 25 533
Lijing Jiao China 16 298 1.0× 124 0.9× 73 0.6× 185 1.6× 50 0.5× 50 615
Shuyu Liu China 14 302 1.0× 138 1.0× 44 0.4× 94 0.8× 38 0.4× 36 544
Shaoqiang Zhang China 16 325 1.1× 127 0.9× 54 0.4× 128 1.1× 62 0.6× 55 666
Qiujun Guo China 14 270 0.9× 140 1.0× 49 0.4× 235 2.0× 139 1.3× 27 761
Lei Dong China 15 812 2.7× 453 3.4× 148 1.2× 158 1.4× 86 0.8× 34 1.3k
Chao Wu China 15 423 1.4× 263 2.0× 27 0.2× 193 1.6× 77 0.7× 62 768

Countries citing papers authored by Xinxing Lai

Since Specialization
Citations

This map shows the geographic impact of Xinxing Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinxing Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinxing Lai more than expected).

Fields of papers citing papers by Xinxing Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinxing Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinxing Lai. The network helps show where Xinxing Lai may publish in the future.

Co-authorship network of co-authors of Xinxing Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Xinxing Lai. A scholar is included among the top collaborators of Xinxing Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinxing Lai. Xinxing Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Tingting, et al.. (2025). The Microbiota-gut-brain axis in vascular cognitive impairment: unraveling the mysterious link and therapeutic prospects. Frontiers in Immunology. 16. 1648800–1648800.
4.
Lai, Xinxing, et al.. (2023). Plasma exosome proteomics reveals the pathogenesis mechanism of post-stroke cognitive impairment. Aging. 15(10). 4334–4362. 9 indexed citations
5.
Liu, Tingting, et al.. (2023). Benefits and risks of antiplatelet therapy for moyamoya disease: a systematic review and meta-analysis. Frontiers in Neurology. 14. 1132339–1132339. 7 indexed citations
8.
Chen, Yuanyuan, Ziyu Tian, Shuyan Wang, et al.. (2022). Trial of a prehospital intervention with traditional Chinese medicine for acute stroke (TRACE): Protocol for a mixed-methods research study. Frontiers in Pharmacology. 13. 879282–879282.
9.
Li, Tingting, Ping Jiang, Dandan Zhang, et al.. (2022). Platelet-activating factor receptor antagonists of natural origin for acute ischemic stroke: a systematic review of current evidence. Frontiers in Pharmacology. 13. 933140–933140. 5 indexed citations
10.
Liu, Tingting, et al.. (2022). Multi-omics approaches for deciphering the complexity of traditional Chinese medicine syndromes in stroke: A systematic review. Frontiers in Pharmacology. 13. 980650–980650. 11 indexed citations
11.
Li, Danxi, et al.. (2022). Cerebral Small Vessel Disease: Neuroimaging Features, Biochemical Markers, Influencing Factors, Pathological Mechanism and Treatment. Frontiers in Neurology. 13. 843953–843953. 26 indexed citations
12.
Yang, Kuo, Zhenhong Liu, Xinxing Lai, et al.. (2022). DrugAI: a multi-view deep learning model for predicting drug–target activating/inhibiting mechanisms. Briefings in Bioinformatics. 24(1). 32 indexed citations
13.
Li, Tingting, Ping Jiang, Ning Liang, et al.. (2022). Edaravone use in acute intracerebral hemorrhage: A systematic review and meta-analysis of randomized controlled trials. Frontiers in Pharmacology. 13. 935198–935198. 5 indexed citations
14.
Zhou, Wuai, Kuo Yang, Jianyang Zeng, et al.. (2021). FordNet: Recommending traditional Chinese medicine formula via deep neural network integrating phenotype and molecule. Pharmacological Research. 173. 105752–105752. 71 indexed citations
15.
Zhou, Wuai, Xinxing Lai, Xin Wang, et al.. (2021). Network pharmacology to explore the anti-inflammatory mechanism of Xuebijing in the treatment of sepsis. Phytomedicine. 85. 153543–153543. 62 indexed citations
16.
Zhang, Siqin, Xinxing Lai, Xin Wang, et al.. (2021). Deciphering the Pharmacological Mechanisms of Guizhi-Fuling Capsule on Primary Dysmenorrhea Through Network Pharmacology. Frontiers in Pharmacology. 12. 613104–613104. 29 indexed citations
17.
Lai, Xinxing, Jian Liu, Tianyi Zhang, et al.. (2020). Clinical, laboratory and imaging predictors for critical illness and mortality in patients with COVID-19: protocol for a systematic review and meta-analysis. BMJ Open. 10(12). e039813–e039813. 7 indexed citations
18.
Zhang, Peng, Mingran Yang, Yiding Zhang, et al.. (2019). Dissecting the Single-Cell Transcriptome Network Underlying Gastric Premalignant Lesions and Early Gastric Cancer. Cell Reports. 27(6). 1934–1947.e5. 299 indexed citations breakdown →
19.
Lai, Xinxing, et al.. (2017). Xingnaojing for Moderate-to-severe Acute ischemic Stroke (XMAS): study protocol for a randomized controlled trial. Trials. 18(1). 479–479. 9 indexed citations
20.
Lai, Xinxing, et al.. (2017). Effects of extended in-patient treatment training on outcome of post-stroke dysphagia.. PubMed. 21(24). 5711–5716. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026